森萱医药
(920946)
| 流通市值：46.01亿 | | | 总市值：46.02亿 |
| 流通股本：4.27亿 | | | 总股本：4.27亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 321,194,740.75 | 160,305,237.6 | 552,577,290.5 | 411,214,920.81 |
| 营业总成本 | 211,008,964.37 | 101,738,509.09 | 390,170,490.59 | 282,805,255.69 |
| 其他经营收益 | | | | |
| 营业利润 | 111,040,535.8 | 58,347,201.73 | 159,649,440.54 | 126,435,222.22 |
| 利润总额 | 110,869,025.71 | 58,343,344.15 | 158,937,574.15 | 126,404,422.04 |
| 净利润 | 94,800,257.18 | 50,128,285.8 | 137,770,973.41 | 108,176,343.68 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | 94,800,257.18 | 50,128,285.8 | 137,770,973.41 | 108,176,343.68 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 874,458,525.69 | 914,335,514.31 | 894,175,178.08 | 865,563,701.86 |
| 非流动资产: | | | | |
| 非流动资产合计 | 590,115,801.77 | 576,275,452.56 | 549,639,887.3 | 536,850,974.45 |
| 资产总计 | 1,464,574,327.46 | 1,490,610,966.87 | 1,443,815,065.38 | 1,402,414,676.31 |
| 流动负债: | | | | |
| 流动负债合计 | 88,346,377.91 | 86,450,719.12 | 93,802,984.01 | 81,853,014.72 |
| 非流动负债: | | | | |
| 非流动负债合计 | 9,288,648.16 | 10,532,828.81 | 8,331,731.89 | 6,318,880.46 |
| 负债合计 | 97,635,026.07 | 96,983,547.93 | 102,134,715.9 | 88,171,895.18 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 1,289,882,999.15 | 1,313,983,487.19 | 1,265,263,311.52 | 1,239,107,942.67 |
| 股东权益合计 | 1,366,939,301.39 | 1,393,627,418.94 | 1,341,680,349.48 | 1,314,242,781.13 |
| 负债和股东权益合计 | 1,464,574,327.46 | 1,490,610,966.87 | 1,443,815,065.38 | 1,402,414,676.31 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 300,455,704.39 | 143,428,590.15 | 535,653,489.17 | 393,482,605.7 |
| 经营活动现金流出小计 | 186,813,347.88 | 90,288,549.94 | 338,895,135.91 | 257,408,464.44 |
| 经营活动产生的现金流量净额 | 113,642,356.51 | 53,140,040.21 | 196,758,353.26 | 136,074,141.26 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 226,930,611.62 | 88,700,197.57 | 305,365,640.69 | 208,435,394.92 |
| 投资活动现金流出小计 | 305,781,833.77 | 143,196,722.6 | 476,590,535.47 | 383,522,124.32 |
| 投资活动产生的现金流量净额 | -78,851,222.15 | -54,496,525.03 | -171,224,894.78 | -175,086,729.4 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 13,000,000 | 3,000,000 | 200,000 | 200,000 |
| 筹资活动现金流出小计 | 73,729,317.14 | 345,768 | 64,236,221.29 | 64,163,203.29 |
| 筹资活动产生的现金流量净额 | -60,729,317.14 | 2,654,232 | -64,036,221.29 | -63,963,203.29 |
| 汇率变动对现金及现金等价物的影响 | -3,233,563.25 | -1,356,308.31 | -1,937,713.43 | -1,223,900.33 |
| 现金及现金等价物净增加额 | -29,171,746.03 | -58,561.13 | -40,440,476.24 | -104,199,691.76 |
| 期末现金及现金等价物余额 | 513,705,935.39 | 542,819,120.29 | 542,877,681.42 | 479,118,465.9 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -29,171,746.03 | - | -40,440,476.24 | - |